These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2138912)

  • 1. The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumor.
    Manda T; Nishigaki F; Mukumoto S; Masuda K; Nakamura T; Shimomura K
    Eur J Cancer; 1990 Feb; 26(2):93-9. PubMed ID: 2138912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity.
    Shimomura K; Manda T; Mukumoto S; Kobayashi K; Nakano K; Mori J
    Int J Cancer; 1988 Feb; 41(2):243-7. PubMed ID: 3338873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice.
    Manda T; Nishigaki F; Mori J; Shimomura K
    Cancer Res; 1988 Aug; 48(15):4250-5. PubMed ID: 3390820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
    Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
    Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
    J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.
    Mulé JJ; Asher A; McIntosh J; Lafreniere R; Shiloni E; Lefor A; Reichert CM; Rosenberg SA
    Cancer Immunol Immunother; 1988; 26(3):202-8. PubMed ID: 3383204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the toxicity of tumor necrosis factor by tumors in mice.
    Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
    Circ Shock; 1994 Oct; 44(2):77-83. PubMed ID: 7743604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.
    Bloksma N; Hofhuis FM
    Cancer Immunol Immunother; 1987; 24(2):165-71. PubMed ID: 3829051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H; Oshima H; Soma G; Mizuno D
    J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism.
    Itoh H; Ito H; Amano H; Noda H
    Jpn J Pharmacol; 1994 Oct; 66(2):265-71. PubMed ID: 7869611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
    Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
    Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents.
    Regenass U; Müller M; Curschellas E; Matter A
    Int J Cancer; 1987 Feb; 39(2):266-73. PubMed ID: 3804497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
    Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
    Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of a recombinant and a mutein type of granulocyte colony stimulating factor on the growth of Meth-A fibrosarcoma with 5-fluorouracil chemotherapy.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
    Biotherapy; 1992; 4(2):81-6. PubMed ID: 1377928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.